SC
ARNA

Sepio Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sepio Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-120,387
Closed -$5.47M – 294
2019
Q4 		$5.47M Buy
120,387
+47,556
+65% +$2.25M 0.52% 64
2019
Q3 		$3.33M Buy
+72,831
New +$4.09M 0.34% 91

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Sepio Capital's ARNA Position: Q1 2020 in Review

Sepio Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 120,387 shares — an estimated $5.47M sold.

Sepio Capital first reported a position in ARNA in Q3 2019 and held it in 2 quarters. The position peaked at $5.47M in Q4 2019. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • Sepio Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Sepio Capital sold 120,387 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $5.47M.
  • Sepio Capital first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 2 quarters.
  • Sepio Capital's Arena Pharmaceuticals Inc position peaked at $5.47M in Q4 2019.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Sepio Capital's 13F filing for Q1 2020, filed 29 Apr 2020.